Infectious Disease Diagnostics Market: By Component (Reagents and Kits, Instruments, Services), By Disease Type (HIV, HBV, HCV, TB, HAIs, Respiratory Infections, STDs, COVID-19, Others), By Technology (Immunoassay, Molecular Diagnostics), By End User (Hospitals and Clinics, Diagnostic Centers, Homecare, Others) and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Infectious Disease Diagnostics Market size was valued at USD 15,380.6 million in 2022 and is poised to grow at a CAGR of 4.4% from 2023-2029. A diagnostic is a laboratory test used to diagnose infectious illnesses with the assistance of trained technicians and clinicians. Various diagnostic procedures and devices are used to test a sample of urine, blood, mucus, or other bodily fluids to determine the causing organism. Based on the disease type HIV/AIDS is anticipated to show a significant growth rate in the market share over the forecasting period. According to the World Health Organisation, infectious diseases such as HIV/AIDS are increasing significantly and in 2020 approximately 37 Mn population were living with HIV of which, 1.5 Mn people were newly infected. Moreover, in the USA, around 1.2 million people have HIV and out of this population 13 percent don’t know it and need testing. Moreover, the companies are focusing on launching new products to maintain growth in the market. The growing prevalence of infectious diseases, greater understanding of the diagnosis increases in government funding, rising healthcare costs and increasing adoption of technologically advanced diagnostic equipment in healthcare organizations also heighten the overall growth of the market.

Infectious Disease Diagnostics Market Key Developments:
  • In May 2021, In May, Beckman Coulter commercialized Access SARS-CoV-2 IgG, a fully quantitative lab-based Immunoglobulin G (IgG) serology test that measures the quantity of antibodies against the virus that causes COVID-19
  • In May 2022 Abbott launches HBsAg Next Assay in India for early detection of Hepatitis B.

Global Infectious Disease Diagnostics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

4.4%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Infectious Disease Diagnostics Market Dynamics

The market is expected to rise as the number of medical laboratories practicing infectious disease diagnostic tests have been increased. Increased prevalence of infectious diseases such as hepatitis, influenza, COVID-19, and HIV, increased demand for infection diagnostic tests, increased funding from private and government organizations for diagnostic service centers, and advancements in infectious disease diagnostic technologies are anticipated to grow the market over the forecasting period. Moreover, rise in awareness about early stage disease diagnosis and government screening programs to lower the incidence rate and mortality are anticipated to burgeon the growth of the infectious disease diagnostics market over the forecast years.

Key Features of the Reports

  •  Infectious Disease Diagnostics Market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Infectious Disease Diagnostics Market Segmentation

By Component
  • Reagents and Kits
  • Instruments
  • Services
By Disease Type
  • HIV
  • HBV
  • HCV
  • TB
  • HAIs
  • Respiratory Infections
  • STDs
  • COVID-19
  • Others
By Technology
  • Immunoassay
  • Molecular Diagnostics
By End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Homecare
  • Others

Frequently Asked Questions

The infectious disease diagnostics market size was valued at USD 15,380.6 million in 2022

The infectious disease diagnostics market's key players are: Abbott Laboratories Becton Dickinson and Company BioMerieus SA Bio-Rad Laboratories Danaher Corporation F Hoffman-La Roche Hologic Inc. Luminex Corporation Qiagen Inc Thermo Fisher Scientific Inc. LumiraDx

The infectious disease diagnostics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1. Executive Summary
2. Global Infectious Disease Diagnostics Market  Introduction 
2.1.Global Infectious Disease Diagnostics Market   - Taxonomy
2.2.Global Infectious Disease Diagnostics Market   - Definitions
2.2.1.Component
2.2.2.Disease Type
2.2.3.Technology
2.2.4. End User
2.2.5.Region
3. Global Infectious Disease Diagnostics Market  Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Infectious Disease Diagnostics Market  Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Infectious Disease Diagnostics Market   By Component, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Reagents and Kits
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Instruments
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Services
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Infectious Disease Diagnostics Market   By Disease Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. HIV
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. HBV
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. HCV
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. TB
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. HAIs
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Respiratory Infections
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. STDs
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. COVID-19
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
6.9. Others
6.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.9.3. Market Opportunity Analysis 
7. Global Infectious Disease Diagnostics Market   By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Immunoassay
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Molecular Diagnostics
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8. Global Infectious Disease Diagnostics Market   By  End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Hospitals and Clinics
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Diagnostic Centers
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Homecare
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Infectious Disease Diagnostics Market   By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Reagents and Kits
10.1.2.Instruments
10.1.3.Services
10.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.HIV
10.2.2.HBV
10.2.3.HCV
10.2.4.TB
10.2.5.HAIs
10.2.6.Respiratory Infections
10.2.7.STDs
10.2.8.COVID-19
10.2.9.Others
10.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Immunoassay
10.3.2.Molecular Diagnostics
10.4.   End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospitals and Clinics
10.4.2.Diagnostic Centers
10.4.3.Homecare
10.4.4.Others
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Reagents and Kits
11.1.2.Instruments
11.1.3.Services
11.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.HIV
11.2.2.HBV
11.2.3.HCV
11.2.4.TB
11.2.5.HAIs
11.2.6.Respiratory Infections
11.2.7.STDs
11.2.8.COVID-19
11.2.9.Others
11.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Immunoassay
11.3.2.Molecular Diagnostics
11.4.   End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospitals and Clinics
11.4.2.Diagnostic Centers
11.4.3.Homecare
11.4.4.Others
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Reagents and Kits
12.1.2.Instruments
12.1.3.Services
12.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.HIV
12.2.2.HBV
12.2.3.HCV
12.2.4.TB
12.2.5.HAIs
12.2.6.Respiratory Infections
12.2.7.STDs
12.2.8.COVID-19
12.2.9.Others
12.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Immunoassay
12.3.2.Molecular Diagnostics
12.4.   End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospitals and Clinics
12.4.2.Diagnostic Centers
12.4.3.Homecare
12.4.4.Others
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Infectious Disease Diagnostics Market  ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Reagents and Kits
13.1.2.Instruments
13.1.3.Services
13.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.HIV
13.2.2.HBV
13.2.3.HCV
13.2.4.TB
13.2.5.HAIs
13.2.6.Respiratory Infections
13.2.7.STDs
13.2.8.COVID-19
13.2.9.Others
13.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Immunoassay
13.3.2.Molecular Diagnostics
13.4.   End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospitals and Clinics
13.4.2.Diagnostic Centers
13.4.3.Homecare
13.4.4.Others
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Component Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Reagents and Kits
14.1.2.Instruments
14.1.3.Services
14.2.  Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.HIV
14.2.2.HBV
14.2.3.HCV
14.2.4.TB
14.2.5.HAIs
14.2.6.Respiratory Infections
14.2.7.STDs
14.2.8.COVID-19
14.2.9.Others
14.3.  Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Immunoassay
14.3.2.Molecular Diagnostics
14.4.   End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospitals and Clinics
14.4.2.Diagnostic Centers
14.4.3.Homecare
14.4.4.Others
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Abbott Laboratories
15.2.2.Becton Dickinson and Company
15.2.3.BioMerieus SA
15.2.4.Bio-Rad Laboratories
15.2.5.Danaher Corporation
15.2.6.F Hoffman-La Roche
15.2.7.Hologic Inc.
15.2.8.Luminex Corporation
15.2.9.Qiagen Inc
15.2.10.Thermo Fisher Scientific Inc.
15.2.11.LumiraDx
16. Research Methodology 
17. Appendix and Abbreviations 
  • Abbott Laboratories
  • Becton Dickinson and Company
  • BioMerieus SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F Hoffman-La Roche
  • Hologic Inc.
  • Luminex Corporation
  • Qiagen Inc
  • Thermo Fisher Scientific Inc.
  • LumiraDx